Table 1 Patient characteristics.
From: Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
Diagnosis | n | Sex female (%) | Age median (range) | Autoantibody | Therapy | Dose |
---|---|---|---|---|---|---|
RA | 15 | 12 (80.0) | 53 (34–68) | anti-CCP | RTX | repeated 1000 mg |
PV | 10 | 7 (70.0) | 56 (31–71) | anti-Dsg3 | RTX | repeated 1000 mg |
AAV | 11 | 4 (36.4) | 53 (21–77) | anti-PR3 | RTX | repeated 1000 mg |
MS | 15 | 6 (40.0) | 57 (46–62) | - | OCR | 2 × 300 mg 2 × 600 mg |